2. Academic Validation
  3. Sulfonylamide Compounds as CDK2 Inhibitors for Treating Cancer

Sulfonylamide Compounds as CDK2 Inhibitors for Treating Cancer

  • ACS Med Chem Lett. 2021 Sep 13;12(10):1528-1529. doi: 10.1021/acsmedchemlett.1c00471.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 34676031 DOI: 10.1021/acsmedchemlett.1c00471
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-139651
    CDK Inhibitor
    CDK